Description

3-[7-(1-Methyl-1H-Pyrazol-4-Yl)[1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl]Propanoic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure. This compound is of significant commercial importance for its role as a key building block in the synthesis of novel, targeted therapeutic agents. It is primarily required by research institutions and pharmaceutical manufacturers engaged in the development of small molecule drugs, particularly in oncology and inflammatory disease pathways.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel kinase inhibitors and other targeted small molecule therapeutics.
• Oncology Drug Discovery: Used in research and development of compounds targeting specific cancer cell proliferation pathways.
• Anti-inflammatory Agent R&D: Serves as a core scaffold for developing new treatments for chronic inflammatory and autoimmune diseases.
• Biochemical Research: Employed as a reference standard or probe in enzymatic and receptor binding studies.
• Contract Manufacturing (CMO): Supplied to contract manufacturing organizations for scale-up synthesis under cGMP conditions.
• Academic Research: Utilized in university and institutional labs for medicinal chemistry and structure-activity relationship (SAR) studies.

Basic Information

Product Name	3-[7-(1-Methyl-1H-Pyrazol-4-Yl)[1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl]Propanoic Acid
CAS No.	1170616-38-2
Molecular Formula	C12H12N6O2
Molecular Weight	272.26 g/mol
Synonyms	3-[7-(1-Methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]propanoic acid; 3-(7-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)propanoic acid; 1170616-38-2; Propanoic acid, 3-[7-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-; AKOS025247315; CS-0446225; FT-0770087; NS-00013575
EINECS	Contact for details

Quality Control

Our 3-[7-(1-Methyl-1H-Pyrazol-4-Yl)[1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl]Propanoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our production can align with cGMP guidelines for pharmaceutical applications upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.